$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Total Current Assets
$544.00M
Quarterly · Period ending: · USD

RARE Total Current Assets
Latest reported$951.00Mperiod ending
Latest reported$951.00Mperiod ending
RARE FY Current Assets ($10.95M → $951.00M)
Annual total current assets
High-resolution chart · PNG
What is total current assets?
Assets expected to be converted to cash within one year.
RARE total current assets history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Current Assets (USD) |
|---|---|
| 951,000,000 | |
| 817,123,000 | |
| 732,184,000 | |
| 883,899,000 | |
| 856,604,000 | |
| 1,295,304,000 | |
| 851,017,000 | |
| 522,369,000 | |
| 244,468,000 | |
| 498,111,000 | |
| 450,207,000 | |
| 187,487,000 | |
| 55,225,000 | |
| 86,445,000 | |
| 10,953,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance